Navigation Links
Brigham and Women's Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
Date:11/19/2008

OTTAWA, Nov. 19 /PRNewswire/ - Vocantas Inc., developer of voice solutions for healthcare, has been selected by Boston's Brigham and Women's Hospital (BWH) to help researchers assess the impact of automated telephone follow-up systems on the management of patients on commonly prescribed medications. Using interactive voice response (IVR) and speech technology, the CallAssure system enables healthcare providers to evaluate real time patient data. Study researchers believe that this proactive outreach may facilitate communication between patients and their physicians between visits to address potentially serious issues.

Leading the project is researcher Jennifer Haas, MD, MSPH, at BWH's Division of General Medicine. Dr. Haas has made major contributions in areas focused on the use of technology to improve the quality and safety of patient care, as well as access to care, particularly among the poor and uninsured.

"After three weeks of pilot test calls, the system is functioning well," says Haas. "We are looking forward to implementing the technology in our trial to quickly and effectively reach participants and to manage the data efficiently."

Supporting HL7 standards, the CallAssure system automatically records any symptoms the patient is experiencing in a note which is then attached to the patient's electronic medical record.

Primary care patients at BWH who are prescribed any of 32 target medications for a range of chronic conditions, from allergies to high cholesterol, are enrolled in the study. Candidates receive a letter explaining how the study works, and may choose to opt out. More than 90% of patients have chosen to try the program at the time of this release.

Aarthi Iyer, MPH with the Division of General Medicine at BWH, explains that there are a number of potential problems that exist with identifying side effects from prescribed medications.

"Typically, medication follow-up is done during the next appointment. This can mean that a lot of time passes without symptoms and side effects being reported." says Iyer. "The automated patient poll serves as check-up between doctor visits."

Another key feature of CallAssure is that the survey is dynamic. Based on the medication and the patient's responses to questions, the survey script will trigger an email notification immediately to a physician for follow-up.

"Previously, information about symptoms and side effects was not collected in a standard and thorough manner," says Iyer. "Now, we are able to test a method that closes that follow-up loop and provides real-time reporting for review and analysis.

"We look forward to exploring potential ways to improve patient safety with new technology, and are happy to be working with the Vocantas team on this project."

About Vocantas

Vocantas is a developer of interactive voice response systems (IVRS) that use advanced computer telephony and speech technology to provide its customers with cost-effective customer outreach solutions. The company's easy-to-use, turn-key solutions offer customizable core features and optional enhancements that integrate seamlessly with existing systems. Its products have particular application in the healthcare, utilities and customer service environments where they have been proven to increase efficiencies while minimizing operational costs. For more information, please visit www.vocantas.com

"CallAssure" is a trademark of Vocantas Inc. The names of other companies

or products mentioned herein may be the trademarks of their respective

owners.


'/>"/>
SOURCE VOCANTAS
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly and Partners In Health, Brigham and Womens Hospital Team Up to Fight MDR-TB in Former Soviet Republics
2. Womenshealthchannel Enhancements Support Pregnant Teens
3. Leeds researchers reshape the future of drug discovery
4. UNC researchers find clue to stopping breast-cancer metastasis
5. U of U researchers to use patients own stem cells to treat heart failure
6. Researchers identify toehold for HIVs assault on brain
7. Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage
8. Researchers Use New Method to Control Bleeding in Hemophilia
9. Stem cells with potential to regenerate injured liver tissue identified by Penn researchers
10. Protein can nurture or devastate brain cells, depending on its friends, researchers find
11. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: